Complementary and Alternative Medicine (CAM) for Fibromyalgia

September 22, 2015 updated by: Scott Mist, Oregon Health and Science University
This study is an acceptability and feasibility study of two adjunctive interventions: group education with stretching; and group acupuncture. The study population will be women with primary fibromyalgia who have not previously used acupuncture in the last 3 months. Both interventions will be 10 weeks in length and will be conducted at the Oregon Health & Science University. The primary hypothesis is that both arms will be acceptable and feasible in the study population.

Study Overview

Study Type

Interventional

Enrollment (Actual)

431

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oregon
      • Portland, Oregon, United States, 97239
        • Oregon Health & Science University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Having met American College of Rheumatology (1990) criteria for the diagnosis of fibromyalgia
  2. Having a primary Traditional Chinese Medicine (TCM) diagnosis of either Liver Qi Stagnation, Qi and Blood Stagnation, or Qi and Blood Deficiency
  3. Female gender
  4. Reported average pain of 5 or higher over last week on a scale of 0 to 10 with ten indicating higher pain.
  5. Willingness to limit the introduction or change of any medications or treatment modalities for control of fibromyalgia symptoms during the study
  6. No TCM in last 3 months (including acupuncture, Chinese herbs or herbal tea pills, tuina (Chinese massage), shiatsu (Japanese massage), qigong and Oriental food therapy)
  7. Ability to travel to the intervention and testing sites up to two times weekly
  8. Being over 18 and under 75 years of age, and
  9. Capability of giving informed consent.

Exclusion Criteria:

  1. Presence of a known coagulation abnormality, thrombocytopenia, or bleeding diathesis that may preclude the safe use of acupuncture;
  2. Individuals with celiac disease
  3. A score greater than 29 on the Beck Depression Inventory
  4. Presence of concurrent autoimmune disease such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, that causes pain and could potentially confound the analysis;
  5. Routine daily use of narcotic analgesics or history of substance abuse;
  6. Concurrent participation in other therapeutic trials;
  7. Pregnant and nursing mothers (verification of pregnancy status will be determined via a urine test);
  8. Severe psychiatric illnesses (current schizophrenia, major depression with suicidal ideation, substance abuse within two years);
  9. Are undergoing disability determination, or are involved in litigation related to fibromyalgia
  10. Any impairment, activity or situation that in the judgment of the PI would prevent satisfactory completion of the study protocol
  11. Cognitive behavioral therapy in the last 6 months.
  12. Non-fluency in English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group Education with Stretching
Group Education with Stretching will receive 10 small group educational classes at the Oregon Health & Science University (OHSU), based on the book "Fibromyalgia (Biographies of Disease)." Each chapter of Fibromyalgia covers different aspects of the disease and its treatment including global, economic, and risk statistics; a timeline of key events in the study of fibromyalgia; common symptoms and diagnostic indicators; natural history of fibromyalgia; pharmacologic and non-pharmacologic treatments; associated disorders and syndromes; and impact of fibromyalgia at home, in the workplace and in society at large. Participants will be informed that they should not start additional treatments until the end of the study and complementary and alternative treatments won't be covered until the last session. Participants will also receive a digital video disk (DVD) covering stretching appropriate for fibromyalgia patients and will be asked to incorporate the DVD over the next 10 weeks.
Experimental: Group Acupuncture
20 treatments in 10 weeks will include individualized acupuncture in a group setting, dietary and lifestyle recommendations each based on the Traditional Chinese Medicine diagnosis (zhang fu) at the time of the visit.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment Participation Rate
Time Frame: 10 weeks
Rates of treatment attendance in both arms
10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Drop out rate
Time Frame: 10 and 14 weeks
Drop out rates in both arms at weeks 10 and 14
10 and 14 weeks
Completion of Evaluation Rates
Time Frame: Weeks 0, 5, 10 and 14
Completion rates of questionnaires and examinations in both arms
Weeks 0, 5, 10 and 14
Fibromyalgia Impact Questionnaire Revised
Time Frame: Weeks 0, 5, 10, and 14
Comparing overall score of the Fibromyalgia Impact Questionnaire - Revised between the two arms over time.
Weeks 0, 5, 10, and 14
Nociceptive Reflex Testing
Time Frame: Weeks 0, 5, 10 and 14
Nociceptive Reflex will be tested at weeks 0, 5, 10 and 14. Changes in nociceptive reflex will be compared within individuals and between arms.
Weeks 0, 5, 10 and 14
Sleep Quality and Daily Activity
Time Frame: Weeks 0, 5, 10, and 14
Sleep quality and daily activity will be measured using Actiwatch. Changes will be explored within individuals and between groups.
Weeks 0, 5, 10, and 14

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Scott D Mist, PhD, MAcOM, Oregon Health and Science University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (Actual)

July 1, 2015

Study Completion (Actual)

July 1, 2015

Study Registration Dates

First Submitted

January 30, 2014

First Submitted That Met QC Criteria

January 30, 2014

First Posted (Estimate)

February 3, 2014

Study Record Updates

Last Update Posted (Estimate)

September 24, 2015

Last Update Submitted That Met QC Criteria

September 22, 2015

Last Verified

September 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fibromyalgia

Clinical Trials on Group Education and Stretching

Subscribe